|
NCT02111200
|
2014-09-01 |
Comparative Efficacy of Phenylbutyrate (PBA) vs. Benzoate in Urea Cycle Disorders
|
Phase 4
|
Recruiting
|
|
NCT02146209
|
2014-06-01 |
Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate.
|
Phase 1
|
Completed
|
|
NCT02026947
|
2014-02-01 |
Sodium Benzoate for Treatment of Attenuated/Transient Psychosis. A Randomized Placebo-controlled Trial.
|
Phase 2
|
Withdrawn
|
|
NCT01908192
|
2013-11-01 |
Adaptive Phase II Study to Evaluate the Safety & Efficacy of Sodium Benzoate as an Add-on Treatment for Schizophrenia in Adolescents
|
Phase 2/Phase 3
|
Recruiting
|
|
NCT01004263
|
2009-12-01 |
A Study to Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)
|
Phase 3
|
Completed
|
|
NCT00812006
|
2009-03-01 |
A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis
|
Phase 3
|
Completed
|
|
NCT00604812
|
2007-12-01 |
Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1)
|
Phase 1
|
Completed
|
|
NCT00597909
|
2007-12-01 |
Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
|
Phase 2
|
Withdrawn
|
|
NCT00516737
|
2007-10-01 |
Study to Test Rizatriptan in the Early Treatment of Acute Migraine (0462-081)
|
Phase 3
|
Completed
|
|
NCT01938183
|
2006-11-01 |
Full-mouth Periodontal Debridement and Metronidazole Gel in Patients With Chronic Periodontitis
|
Phase 2
|
Completed
|
|
NCT00111709
|
2005-06-01 |
Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-071)
|
Phase 3
|
Completed
|
|
NCT00111722
|
2005-05-01 |
Study to Test a Marketed Drug in the Treatment of Menstrual Migraine (0462-072)
|
Phase 3
|
Completed
|
|
NCT00095004
|
2004-10-01 |
Study to Test an Approved Product in the Early Treatment of Migraine (0462-066)
|
Phase 3
|
Completed
|
|
NCT00092963
|
2004-08-01 |
Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)
|
Phase 3
|
Completed
|
|
NCT00898677
|
1995-09-01 |
Rizatriptan 5 mg and 10 mg, Sumatriptan 100 mg, and Placebo Comparison Study (0462-030)
|
Phase 3
|
Completed
|
|
NCT00897104
|
1995-08-01 |
MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029)
|
Phase 3
|
Completed
|
|
NCT00899379
|
1995-04-01 |
Treatment of Multiple Attacks of Acute Migraine (0462-025)
|
Phase 3
|
Completed
|
|
NCT00897949
|
1995-03-01 |
MK0462 in Treatment of Migraine With Recurrence (MK0462-022)
|
Phase 3
|
Completed
|
|
NCT00004767
|
1985-01-01 |
Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders
|
Phase 2
|
Completed
|